GlassScriptPhysician profile
Kevin W Mcneely
NPI 1972605525
$2,421.67
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $810 · 2020: $352 · 2021: $539 · 2022: $279 · 2023: $377 · 2024: $64.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $846.95 | 2019-2023 | |
| Therapeuticsmd, INC. | $298.18 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $227.60 | 2021-2023 | |
| Astellas Pharma US INC | $117.97 | 2019-2024 | Veozah |
| Sage Therapeutics, LLC | $106.13 | 2020 | |
| Pfizer INC. | $103.99 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.53 | 2019-2020 | |
| Organon LLC | $80.17 | 2022-2023 | Nexplanon |
| Myovant Sciences INC. | $79.21 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $78.02 | 2019-2021 | |
| Coopersurgical, INC. | $67.22 | 2019-2022 | |
| Allergan, INC. | $63.08 | 2019 | |
| Duchesnay USA Incorporated | $49.54 | 2019 | |
| Exeltis, USA INC. | $41.08 | 2021-2023 | Slynd |
| Sumitomo Pharma America, INC. | $30.73 | 2023 | Myfembree |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $30.50 | 2019 | |
| Ethicon US, LLC | $26.88 | 2020 | |
| Evofem Biosciences, INC. | $20.14 | 2021 | |
| Minerva Surgical, INC | $19.46 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $17.09 | 2023 | Vivjoa |
| Ascend Therapeutics US, LLC | $16.97 | 2023 | |
| Amag Pharmaceuticals, INC. | $16.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Mcneely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.